Genezen (USA) is a leading cell and gene therapy CDMO founded in 2014, specializing in lentiviral, retroviral, and adeno-associated viral (AAV) vector manufacturing. The company operates a 60,000 sq ft cGMP facility in Fishers, Indiana and an 86,000 sq ft licensed facility in Lexington, Massachusetts. Genezen provides end-to-end services from preclinical through commercial manufacturing, with FDA registration and established manufacturing partnerships.
Viral vector CDMO, lentiviral vectors, retroviral vectors, AAV vectors, cell therapy CDMO, commercial manufacturing partnerships
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.